Effect of fluvastatin-treatment on the proteome and phosphor-proteome in metastatic pancreatic cancer cells
Ontology highlight
ABSTRACT: Fluvastatin has been identified as novel inhibitors of metastasis in pancreatic cancer. In multiple in vivo and in vitro experiments the compounds phenotypic effects was validated. Since under drug treatment the transcriptomic changes in examined cell lines were rather small, we expected the underlying mechanistic effect to be on the level of the proteome and more importantly the phospho-proteome. To evaluate this assumption we performed label-free full proteome and phosphoproteomics experiments on Fluvastatin treated ASPC1 cells.
INSTRUMENT(S): Orbitrap Fusion Lumos
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Cell Culture
DISEASE(S): Pancreatic Ductal Adenocarcinoma
SUBMITTER: Farnusch Kaschani
LAB HEAD: Farnusch Kaschani
PROVIDER: PXD022345 | Pride | 2021-11-29
REPOSITORIES: Pride
ACCESS DATA